Skip to main content
Clinical Trials/NCT01668251
NCT01668251UnknownNot Applicable

National Collaborative Study of Girls Prenatally Diagnosed With Turner Syndrome Karyotypes

Seattle Children's Hospital1 site in 1 country60 target enrollmentStarted: January 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
60
Locations
1
Primary Endpoint
Number of signs of Turner syndrome

Study Overview

Brief Summary

The goal of this study is to compare the features of Turner syndrome in girls who are diagnosed before birth because of fetal concerns versus those who are diagnosed when their mother has an amniocentesis for another reason.

Detailed Description

This is an observational study which will look at girls who are diagnosed with Turner syndrome before they are born. Girls will be divided into two groups: 1) those diagnosed because of features seen on ultrasound which raised the question of Turner syndrome and 2) those diagnosed incidentally when their mother had an amniocentesis for another reason such as advanced maternal age.

No clinical procedures nor interventions will be done as part of this data collection study which will occur for the first 3 to 6 years of the girl's life. The investigators will be looking to see if girls who are diagnosed incidentally have less features of Turner syndrome than those girls who are diagnosed because of fetal ultrasound.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
— to 3 Months (Child)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Turner syndrome diagnosed prenatally
  • Less than 4 months of age at time of enrollment

Exclusion Criteria

  • Turner syndrome diagnosed postnatally
  • Older than 4 months of age at time of enrollment

Outcomes

Primary Outcomes

Number of signs of Turner syndrome

Time Frame: three to six years

Girls diagnosed with Turner syndrome by fetal ascertainment will have more signs of Turner syndrome than girls diagnosed by maternal ascertainment

Secondary Outcomes

  • Growth(three to six years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Patricia Fechner

Associate Professor, Pediatrics

Seattle Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials